Background
Understanding the natural history of rare bone and mineral conditions is essential for improving clinical practice and the development of new diagnostics and therapeutics. Recruitment and long-term participation in registries are key challenges for researchers.
To understand the user needs, the European Reference Network on Rare Bone Diseases (ERN BOND) and European Patient Advocacy Groups developed and implemented a multinational survey about the patient’s preferred database content and functionality. Findings were analysed using descriptive statistics and regression methods.
Results
There were 493 eligible responses from 378 adults, 15 children and 100 parents, guardians or carers (PGC) across 22 rare bone and mineral conditions. Osteogenesis imperfecta constituted 53.4% of responses. Contents related to improving treatment and medical services scored the highest and contents about anxiety and socializing scored less highly. Additional content was recommended by 205 respondents. Respondents preferred data entry by their Healthcare Provider (HCP). However, less than 50% of adults received followup from their specialist HCP at least annually and 29% were followed up as needed.
Conclusions
This survey of individuals, their family, guardians and carers has prioritised the key components for an EU-based rare bone and mineral condition research database. The survey highlights issues around collecting psychosocial impacts as well as measures of HCP trust. The survey demonstrated that using only specialist centre visits for data collection, while preferred by patients, will miss a substantial number of individuals, limiting generalisability. Combined HCP and patient platforms will be required to collect representative and complete natural history data for this patient group.
Figure 1
Figure 1
Figure 1
Figure 2
Figure 2
Figure 2
Figure 3
Figure 3
Figure 3
Figure 4
Figure 4
Figure 4
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Posted 10 Dec, 2020
On 24 Jan, 2021
Received 10 Jan, 2021
Received 01 Jan, 2021
Received 01 Jan, 2021
On 31 Dec, 2020
On 29 Dec, 2020
Invitations sent on 28 Dec, 2020
On 28 Dec, 2020
On 04 Dec, 2020
On 04 Dec, 2020
On 04 Dec, 2020
On 15 Nov, 2020
Posted 10 Dec, 2020
On 24 Jan, 2021
Received 10 Jan, 2021
Received 01 Jan, 2021
Received 01 Jan, 2021
On 31 Dec, 2020
On 29 Dec, 2020
Invitations sent on 28 Dec, 2020
On 28 Dec, 2020
On 04 Dec, 2020
On 04 Dec, 2020
On 04 Dec, 2020
On 15 Nov, 2020
Background
Understanding the natural history of rare bone and mineral conditions is essential for improving clinical practice and the development of new diagnostics and therapeutics. Recruitment and long-term participation in registries are key challenges for researchers.
To understand the user needs, the European Reference Network on Rare Bone Diseases (ERN BOND) and European Patient Advocacy Groups developed and implemented a multinational survey about the patient’s preferred database content and functionality. Findings were analysed using descriptive statistics and regression methods.
Results
There were 493 eligible responses from 378 adults, 15 children and 100 parents, guardians or carers (PGC) across 22 rare bone and mineral conditions. Osteogenesis imperfecta constituted 53.4% of responses. Contents related to improving treatment and medical services scored the highest and contents about anxiety and socializing scored less highly. Additional content was recommended by 205 respondents. Respondents preferred data entry by their Healthcare Provider (HCP). However, less than 50% of adults received followup from their specialist HCP at least annually and 29% were followed up as needed.
Conclusions
This survey of individuals, their family, guardians and carers has prioritised the key components for an EU-based rare bone and mineral condition research database. The survey highlights issues around collecting psychosocial impacts as well as measures of HCP trust. The survey demonstrated that using only specialist centre visits for data collection, while preferred by patients, will miss a substantial number of individuals, limiting generalisability. Combined HCP and patient platforms will be required to collect representative and complete natural history data for this patient group.
Figure 1
Figure 1
Figure 1
Figure 2
Figure 2
Figure 2
Figure 3
Figure 3
Figure 3
Figure 4
Figure 4
Figure 4
This is a list of supplementary files associated with this preprint. Click to download.
Loading...